Breaking News, Collaborations & Alliances

CatSci and Argonaute RNA Enter CMC Development Collaboration

Aim to expedite oligonucleotide manufacturing for gene-silencing therapeutics.

Author Image

By: Charlie Sternberg

Associate Editor

CatSci Ltd, a scientifically-led, commercially-minded and award-winning innovation partner for medicines development, and Argonaute RNA, a biotech developing safe and reliable methods for transient silencing of target genes in different tissue cells, have entered a chemistry, manufacturing and control (CMC) development collaboration focused on novel therapeutic oligonucleotides.   The new collaboration is underpinned with significant upfront investment into Argonaute RNA by CatSci, and the appoi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters